Advertising and Marketing, Business, e-Commerce, Free News Articles, Patent and Trademark

Fanplayr Issued U.S. Patent on Segmentation as a Service

PALO ALTO, Calif. -- Fanplayr, a leader in online behavioral personalization and artificial intelligence for the past decade, announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 10,958,743 which is related to the use of true first party observed data to offer behavior personalization focused on growing revenues for Fanplayr customers.

U.S. Patent No. 10,958,743 was issued on March 23, 2021 and covers the use of "Method and System for Segmentation as a Service" by Fanplayr.

"Segmentation as a Service" enables Fanplayr's powerful segmentation engine to be deployed for real-time segmentation with multiple apps, 3rd party systems, and combining first-party data with CRM and CDP historic data. The patent recognizes that Fanplayr is the only technology company offering segmentation as a broadly available service in the global ecommerce industry.

The technology disclosed in the patent modularizes the real-time evaluation of first-party data that reflects individual experiences and then defines an interface wherein the actions of remote, third-party services can be invoked. This enables such remote services to become increasingly fit for purpose without having to deal with the complexity and meaning of each individual visit. Such visits have context, such as purchase and visit history, site pattens and market trends, individual and collective behavioral indicators that remote services have limited awareness of.

Through the use of Segmentation As A Service, Fanplayr dramatically reduces the technical challenge of integrating state-of-art AI and IOT technologies and optimizes their relevance to each visit as it happens.

The patent includes various use cases that illustrate its claims, such as creating better visitor awareness in chatbots, survey widgets, credit calculation algorithms, cart margin evaluations and intelligent recommendations of products and articles.

The patent will remain in effect until 2038. Corresponding international patent filings in Europe, UK, China, HK, and Australia are pending grant.

At the heart of the Fanplayr method is true, first-party data which refers to information gathered in real-time, that is actionable as it happens, and originates from its primary source.

"In the current AdTech ecosystem, historical tracking data from cookies is not only less reliable but those third-party cookies are in the process of being phased out by pending privacy changes," says Derek Adelman, Co-founder and Vice President of APAC for Fanplayr. "Fanplayr's Seg-As-A-Service technology allows the customer to have confidence in services that have a more complete awareness of visitor experiences. Because they operate from data that is pure and actionable and see it as it happens, they not only deliver a consistently better result, but they can enjoy continuous improvement as these services become more visitor aware and more fit to their purpose."

Simon Yencken, Fanplayr CEO & Co-founder, says the technology required significant foresight and development. "Ten years ago, we saw that the future of the digital world would be understanding visitors in a responsive but non-intrusive way, as a digital replication of the interaction between a salesperson and a customer," says Yencken. "This patent recognizes the originality and uniqueness of our approach, thus protecting the intellectual property (IP) and establishing a strong defense from would-be competitors. We are extremely pleased with the patent issuance as a critical step in our product development, differentiation, and global expansion for Fanplayr."

With an enormous surge in e-commerce in the last year, Fanplayr's expansion has been driven by its ability to convert online users into buyers for companies of all sizes. Customers range from notable high-end fashion retailers and hotels to banking and major software brands. The company has expanded with operations in top global markets, including the U.S., United Kingdom, Mexico, Brazil, Japan, and the Middle East among others.

In addition to steadily increasing its global footprint, Fanplayr has announced several new services, or "products," in the past year, including Product Recommendations and SMS Messaging for brands. "Our goal is to offer a full range of products, to preserve the integrity of the data we capture and also to provide the most comprehensive system of artificial intelligence and behavior analysis available, thereby ensuring positive results for our customers," says Rajiv Sunkara, Co-founder and CTO of Fanplayr.

From its global headquarters in Palo Alto, California, Fanplayr has been leading fully integrated online personalization and AI for a decade. The company has achieved consistent growth of more than 60% annually over the last several years.

About Fanplayr

Fanplayr is a global leader in e-commerce behavioral data, using machine learning and AI to enable businesses to increase conversion rates and revenue, collect more leads, and retarget visitors with personalized recommendations during and after the shopping experience. Fanplayr is headquartered in Palo Alto, California with offices in New York, Buenos Aires, Brazil, Mexico, Milan, London, Manchester, Amsterdam, Stockholm, Hamburg, Melbourne and Tokyo.

Learn more at: https://www.fanplayr.com/

Media Contact:
Lacy Talton
(252) 467-5220
ltalton@percepture.com

*PHOTO link for media: https://www.Send2Press.com/300dpi/21-0414s2p-fanplayr-300dpi.jpg
*Photo Caption: Rajiv Sunkara, Simon Yencken and Derek Adelman.

Related link: https://www.fanplayr.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Patent and Trademark

Marijuana Home Gardens Announces its Outdoor Grow Hut Kit is Patent Pending – Legal in Arizona

TEMPE, Ariz. -- Tempe, Arizona-based, Marijuana Home Gardens announces it has filed for a patent on its turnkey Outdoor Marijuana Grow Hut Kit (USPTO application: US 63/163,586).

The passage of the Smart and Safe Act (Arizona Proposition 207) not only made the use of recreational marijuana legal in Arizona, but also, residents are now allowed to grow and harvest for personal use up to 12 marijuana plants per household.

A craft traditionally done indoors and in secret, the new law permits Arizona residents to come out of the shadows and grow high-value marijuana plants outdoors, which has substantial advantages to growing indoors.

With 5 years of experience in growing medicinal marijuana plants, company co-founder, Dante Schettino, has established a successful track record of not only growing outdoors, but all year long during extreme weather conditions from searing heat to freezing temperatures.

"Growing outdoors is tremendously cheaper, significantly safer, easier to maintain, and will result in larger yields," says co-founder Dante Schettino. "While there are plenty of indoor grow kits available for purchase in the marketplace, nobody has created an optimal system for growing outdoors."

For that reason, Schettino and his partners set out to create the Outdoor Grow Hut, a marijuana grow house that maximizes plant growth and minimizes all equipment and maintenance costs.

The Outdoor Grow Hut's patentable design presents a secure structure with limited visibility of the inside plants, but also allows a high degree of sunshine to reach the plants and provides natural air circulation.

The roof is convertible with an open design that permits maximum sunlight exposure during prime growing seasons and can be equipped with additional seasonal tops to protect plants from intense summer sun or trap heat for fall and winter plantings.

Arizona residents can purchase a complete Outdoor Grow Hut kit that includes premium organic super soil, seeds from a third party partner ( http://www.marijuanaseedconnect.com/ ), planter pots, and a watering system.

The company will deliver and install the structure, as well as plant the first seeds. The company also offers optional service contracts where skilled marijuana growers will come to its customers' homes on a weekly basis and cultivate the plants and treat the soil to ensure a constant crop.

"Similar to a pool cleaning service, we will come to your house and do all the gardening and you just sit back and enjoy the benefits," says Schettino.

Because marijuana legalization is a national trend, the company also provides complete Outdoor Grow Hut kits, less the premium organic super soil, for easy nation-wide shipping.

About Marijuana Home Gardens

Based in Tempe, Arizona, Marijuana Home Gardens makes the Outdoor Grow Hut Kit, provides gardening services, and other marijuana harvesting services for Arizona residents. For more information on Marijuana Home Gardens, visit http://www.outdoorgrowhut.com/ or contact us at info@outdoorgrowhut.com or call (480) 780-6763.

Instagram: outdoorgrowhut

Facebook: outdoorgrowhutkits

For more information on Marijuana Seed Connect, visit http://www.marijuanaseedconnect.com/

MEDIA ONLY CONTACT:
Dante Schettino
Marijuana Gardens AZ, LLC
info@marijuanahomegardens.com
(480) 780-6763

Related link: https://www.marijuanaseedconnect.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Drugs and Pharmaceuticals, Free News Articles, Patent and Trademark

Zeteo Biomedical Receives US Patent for Innovative Sublingual Delivery Device for Vaccines and Pharmaceuticals

AUSTIN, Texas -- Zeteo Biomedical, a privately held, biomedical device company, announced today it has been awarded a United States Patent for its "Oral Delivery Device and Methods" (US Patent 10238577). This latest patent expands the capabilities of Zeteo's ZEOx1™ Delivery Platform to systemically deliver drugs or biologics, into the body non-invasively via the sublingual route.

Sublingual delivery has emerged as a viable route of administration for vaccines and medications for pain, cardiovascular, allergy, seizure, sedation and emesis. The sublingual route avoids first pass metabolism and provides rapid systemic uptake into the body providing advantages over traditional oral medications.

Zeteo's latest innovations expand its ZEOx1 Hydra™ sublingual delivery device family that include configurations for mono-dose disposable and mono-dose reloadable dispensers for vaccines, drugs, biopharmaceuticals, biologics and botanical liquid formulations. "We see expanding demand for metered dose sublingual delivery devices that are easy to use, convenient to carry, deliver a precise dose and can be self-administered," said Timothy Sullivan, President of Zeteo Biomedical.

Zeteo's delivery device technology and product integration services enable pharmaceutical and biotech manufacturers to develop drug/device combination products that can extend or establish market exclusivity and competitive differentiation for new or existing drugs and biologics. The shift to developing value added, patient-centric products benefit the consumer through improved compliance and health outcomes while building brand value for the pharmaceutical or biotech manufacturer. Zeteo's delivery platforms and products are designed to meet the diverse demands of consumers and pharma manufacturers in globally competitive markets.

About Zeteo Biomedical LLC

Zeteo Biomedical™ is a biomedical device technology company based in Austin, Texas. Zeteo provides patient-centric delivery device technology and unit dose fill/finish packaging for pharmaceuticals, biopharmaceuticals, biologics and botanicals for intranasal, nose-to-brain, ophthalmic, sublingual, and animal care product applications.

For more information, please visit the Zeteo website at: https://www.zeteobiomed.com/

Media Contact
Cathy Diehl
Zeteo Biomedical LLC
+(1) 512-614-0144
zeteo@zeteobiomed.com

*LOGO link for media: https://www.send2press.com/300dpi/20-1117s2p-zeteo-biomedical-300dpi.jpg

Related link: https://www.zeteobiomed.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Drugs and Pharmaceuticals, Free News Articles, Patent and Trademark

Caisson Biotech, LLC and Heparinex, LLC Announce Positive Examination Report of European Patent and the Discovery of a New Class of Sugar Polymers

AUSTIN, Texas -- Caisson Biotech and parent company Heparinex are pleased to announce that they have received a positive examination report from the European Patent Office for a patent covering the chemoenzymatic production of heparosan utilized in the HEPtune® drug delivery platform. Once certified, the new patent family will increase patent coverage across Europe, adding to the U.S. holdings.

The HEPtune platform, which utilizes heparosan, a naturally occurring polysaccharide, has been validated as a novel half-life extension and drug delivery alternative to commonly used polyethylene glycol (PEG). Unlike PEG, heparosan is naturally found in humans, is completely biodegradable, and will not trigger anaphylactic shock or anti-drug antibodies. The HEPtune platform has been applied to numerous drug classes including biologics, and small molecules via nanocarriers, including liposomes.

In addition to positive news received by the EPO, Heparinex is excited to announce that it has created a new class of sugar polymers, sulfated hepbiuronic acid (sHBA) that mimic some, but not all, of the desirable activities of heparin, a drug employed to treat many diseases including the fight against severe COVID-19 and influenza. These novel patent-pending drug candidates can quell the initiation of inflammation, but do not inhibit blood coagulation, thus can be used to protect organs such as the lungs, heart, and kidneys that are often damaged by the body's own defenses during disease without the risk of bleeding. The sHBA should be a useful addition to the arsenal of drugs currently dispensed to treat hyper-inflammation spawned by infectious, cardiovascular, and auto-immune diseases.

Heparosan conjugation was developed by Presidential Professor Dr. Paul DeAngelis at the University of Oklahoma Health Sciences Center (OUHSC) and includes a robust U.S. and international patent portfolio. "Our goal is to decipher and harness the natural 'sugar codes' in the body in more selective, customized fashion to target diseases and reduce side effects. We are excited by the possibilities for better medicines", said DeAngelis. He was named as one of the most influential researchers in the world according to a study led by an investigator at Stanford University and published in PLOS Biology.

About Caisson Biotech, LLC

Caisson Biotech, LLC is a collaboration driven biotechnology company specializing in the development of heparosan polymers to improve therapeutic drug delivery and performance. Caisson's HEPtune® technology was invented by Chief Scientist and University of Oklahoma Professor Dr. Paul DeAngelis, a world renowned glycobiology and enzyme specialist. Visit: https://caissonbiotech.com/.

Caisson Biotech is a subsidiary of Heparinex, LLC.

About Heparinex, LLC

Heparinex, LLC is a biopharmaceutical company focused on the novel recombinant synthesis of sugar-based compounds for markets including anticoagulation, inflammation, and cancer treatment. Dr. Paul DeAngelis originally discovered and patented Heparinex's core technology platforms of proprietary carbohydrate production. Visit: https://heparinex.com/.

Heparinex and Caisson are funded and managed by Emergent Technologies, Inc. an innovation solutions and technology commercialization leader headquartered in Austin, Texas. Visit: http://www.emergenttechnologies.com/

Related link: https://caissonbiotech.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Legal and Law, Patent and Trademark

Bug-A-Salt Files Patent Infringement Suit Against Dillard’s Inc.

LOS ANGELES, Calif. -- Skell, Inc., dba Bug-A-Salt, has filed suit against the department store chain Dillard's and its distributor, William E. Connor & Associates, for infringing on Skell's 2013 patent for a "bug killing gun," according to Bug-A-Salt's attorney, Liat Cohen.

The complaint was filed in United States District Court of Delaware, case 1:20-CV-01567-UNA.

In the suit, Loren Maggiore, the inventor of Bug-A-Salt, defines his invention as, "A 'gun' that uses table salt as particulate projectiles to stun or kill insects, particularly flies."

The patented Bug-A-Salt gun, which is safe around children and pets, has been on the market since 2013. More than three million Bug-A-Salt units have been sold; revenue from several versions of the product have resulted in sales in excess of $100 million.

In December 2019, Skell management became aware that Dillard's was offering for sale a near-identical Chinese-manufactured product it called "Salt War Gun." That same month, Skell sent a cease-and-desist letter to Dillard's, demanding they stop selling the counterfeit item. Dillard's responded they would do so, and later confirmed that the "Salt War Gun" had been removed from all of its stores. Subsequent investigation showed the patent-infringing product was still available at Dillard's in Florida and other Dillard's stores.

According to an article in the Jan. 26 issue of Barron's magazine, Dillard's was the second-most shorted small-cap stock on the Russell 2000 index, behind GameStop.

Little Rock, Arkansas-headquartered Dillard's has more than 300 locations in 29 US states.

"I first came up with this crazy idea more than 30 years ago, and never dreamt it would become the international success that it has," Maggiore says. "With Dillard's acknowledging our patent but not terminating its sales of its knock-off product, this is a case of the typical small entrepreneur fighting against the corporate giant refusing to do the right thing," he says.

To contact Liat Cohen, Esquire, regarding this suit, call (818) 579-9996 or email her at https://liatlaw.com/.

Related link: https://liatlaw.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Manufacturing, Patent and Trademark, Product Launches

LuciGold Inc. is Helping Protect the Health and Safety of Our Community One Breath at A Time

EAST WAREHAM, Mass. -- LuciGold™ today announced the development of our newest product line, Hygeia (patent pending*), a custom designed line of furniture with built-in High Efficiency Particulate Air (HEPA) Filtration Systems.

Peter Luciani, the founder of LuciGold™, chose the name because he felt it to be most suitable for his new product line as Hygeia was the Ancient Greek Goddess of Good Health.

Hygeia is being introduced at a critical time during our healthcare crisis when we are trying to get children back in schools, employees out of their homes and back to the offices, patrons back to social activities, etc. The ongoing isolation that we as a community have been experiencing has had a profound negative impact on our emotional and mental wellbeing.

It is time there was a solution that would allow people to feel safer in environments where they will be gathering in close; proximity to one another and we feel that Hygeia furniture will assist in everyone getting back to the "old normal."

Hygeia products will be available to the public immediately. All the furniture is custom designed to meet the specifications of the environment where they will be installed.

FEATURES & BENEFITS of HYGEIA FURNITURE FILTRATION SYSTEMS

* HEPA filtration systems remove from the air that passes through it at least 99.95 (EU standard) or 99.97% (ASME, U.S. DOE standards) of particles whose diameter is equal to 0.03 μm; with the filtration efficiency increasing for particle diameter both less than and greater than 0.3μm.

* Fugitive Capture Design pulls exhaled breath through the vents on the top of the desk, restaurant table or bar into a plenum and through the HEPA filtration system reducing airborne transmission of viruses.

* 24/7 filtration with the HEPA filter to the entire room.

About LuciGold Inc.

LuciGold™ located in the heart of Buzzards Bay, Mass., has been family owned and operated since 2004. The owner, Peter J. Luciani, Jr., has been a problem-solver for over 40 years and the sole designer of the entire line of products and continues to develop solutions that address health and safety of the community. "When It Comes to Safety, We Are Committed to Top-of-the-Line Gold Standard."

Learn more at: https://www.LuciGoldHygeia.com

*NOTE: USPTO Patent application 29/760,562

Follow Us at:
- https://twitter.com/LucigoldH
- https://www.facebook.com/LuciGoldHygeia
- https://www.pinterest.com/218cr8vor25el9yzm0hb1t8czcrg0f/
- https://www.instagram.com/LuciGoldHygeia

MULTIMEDIA:

PHOTO link for media: https://www.Send2Press.com/300dpi/20-1214s2p-lucigold-hygiea-desk-300dpi.jpg

Caption: Hygiea Desks with vents that pull exhaled breath through a plenum and into the HEPA Filter

Related link: https://www.LuciGoldHygeia.com

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Patent and Trademark, Software

FormFree Receives US Patent for Its Ground-Breaking Approach to Credit Decisioning

ATHENS, Ga. -- FormFree® has been granted Patent Number 10,769,723 for its proprietary 'Systems and Methods for Electronic Account Certification and Enhanced Credit Reporting' by the United States Patent and Trademark Office. The patent is expected to cover FormFree's technology, which analyzes direct-source financial data to determine a consumer's ability to repay any type of loan, offers a more accurate and comprehensive measurement of ability to pay (ATP) than traditional credit scoring.

The announcement underscores FormFree's focus on creating technologies that enable a more financially inclusive U.S. economy.

"This patent is another important milestone in strengthening our intellectual property position. Nearly 50 million Americans - disproportionately including the poor and minorities - lack a credit score and cannot obtain mortgages or other lending products," said FormFree Founder and CEO Brent Chandler. "FormFree understands that every consumer has a quantifiable ability to pay, not just those with a 720 or higher credit score. We are reimagining credit scoring with a new framework that provides a more complete understanding of what a person can actually afford than merely reviewing their repayment history."

Added Chandler, "Our multi-dimensional analysis of ability to pay allows lenders to instantaneously understand risk and make better credit decisions. It also democratizes lending by putting control of the process in the hands of borrowers, making it easier for consumers to seek out financial institutions that want their business."

The issued patent validates the innovation and novelty in FormFree's technology. FormFree was founded in 2008 by former Wall Street executive Brent Chandler. The company's pioneering work in bringing direct-source data analytics to the U.S. mortgage market has earned it six appearances on the HousingWire Tech100 list of the housing economy's most innovative companies, among other accolades. FormFree's AccountChek® and Passport(tm) solutions are used by thousands of lenders and millions of consumers each year.

About FormFree:

FormFree is a market-leading fintech company whose revolutionary products AccountChek and Passport are building a more inclusive credit decisioning landscape by encouraging lenders to view borrower ability to pay (ATP) more holistically. To date, thousands of U.S. lenders and brokers have ordered millions of FormFree's patented verification reports representing over a trillion dollars in loan verifications. FormFree delights borrowers and lenders with a paperless experience, reduces origination timelines by up to 20 days and offers automated analysis and standardized delivery to lenders and investors using a secure ReIssueKey™.

For more information, visit https://www.formfree.com/ or follow FormFree on LinkedIn https://www.linkedin.com/company/formfree/.

Twitter: @RealFormFree #patentnews #mortgageindustry #fintech

*LOGO link for Media: https://www.Send2Press.com/300dpi/17-0926s2p-formfree-300dpi.jpg

Related link: https://www.formfree.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Environment and Ecology, Free News Articles, Patent and Trademark, Software

Revealiency Announces Issuance of US Patent Covering AI-Powered Autonomous Emissions Testing, Analysis, and Reporting Technology

LEHI, Utah -- Revealiency (aka Emissions-Based Maintenance or EBM) is a Clean Technology company that focuses on optimizing compression ignition engine performance by sampling, and analyzing, engine exhaust using EBM Artificial Intelligence (AI) software to identify corrective maintenance actions that can be taken by engine owners.

Revealiency focuses on commercial and industrial engines that operate over long periods at high-duty cycles. Therefore, even small improvements identified by EBM's technology yields significant benefits.

Today, EBM proudly announces that it has secured US Patent No. US 2020/0109677 A1 - Engine emission status-based maintenance, which autonomously monitors exhaust-gases and provides actionable maintenance corrective actions that can be taken to improve engine performance. By doing so, this technology can also verify an engine is operating within specified parameters.

Benefits of the technology include: 1) reduced environmental impact, 2) lower operating costs, 3) enhanced engine reliability, and 4) improved engine life.

"I am pleased to see the development of this new EBM AI technology. It has been developed using decades of science-based research and hands-on experience with thousands of diesel engines," said Steve "Skinner" Forbush, Co-Founder and Lead Technical Engineer. "This patent leverages recent technological advancements in industrial IoT (telematics) devices with decades of emissions-based engine research."

EBM AI co-inventor and Revealiency Co-Founder and President, Jeramiah Forbush, added, "Many engine owners rely on OEM systems to monitor engine performance and assume that modern computer-controlled engines operate as they were designed. We have collected thousands of emissions tests and typically identify considerable opportunities to improve engine performance. This new AI technology allows for an increase in the frequency of emissions testing while completely automating the testing, analysis, and reporting functions."

For more information on how this patented technology might benefit your business, contact Jeramiah Forbush at jforbush@revealiency.com or (801) 901-8258.

About Revealiency

Revealiency is a clean technology company that focuses on improving commercial and industrial engine performance by identifying engine maintenance opportunities. This is done by sampling and analyzing engine exhaust using EBM AI technology. In recent projects, EBM AI has produced emissions and fuel savings of more than the 5%-7% targets. EBM has prided positive results with customers on six continents. Revealiency has identified corrective actions that can be taken to save over 2 Billion pounds of CO2 from the environment, which is equivalent to the annual CO2 production of over 900,000 automobiles.

Learn more at: https://revealiency.com/

Related link: https://revealiency.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Free News Articles, Legal and Law, Patent and Trademark, Reports and Studies, Software

Patent Bots LLC Releases New Legal Rankings for Tracking Patent Quality

SOMERVILLE, Mass. -- Patent Bots today announced its Patent Law Firm Quality Scores, a new ranking of 802 U.S. patent law firms with at least 50 issued patents for the year ending March 31, 2020. Patent Bots downloaded 310,842 publicly available patents from the United States Patent and Trademark Office and then used the company's AI-powered, automated patent proofreading tool to count the number of errors in each issued patent. Issued patents identify the law firm responsible for the patent and also the company that owns the patent.

The Patent Law Firm Quality Scores provide public recognition for patent firms doing exceptionally high-quality work in avoiding legal errors in issued patents. The Quality Scores show the names of only the top fifty firms (e.g., those with the lowest number of errors per issued patent). Patent law firms outside of the top 50 can login to the Patent Bots website to see their own quality scores and where they stand with respect to other patent law firms.

"Automated patent proofreading helps decrease the number of errors in issued patents," says Jeff O'Neill, Patent Bots Founder and CEO. "Patent law firms are recognizing the importance of doing quality work and are subscribing to our proofreading tool to move up in our rankings."

Benefits of the Quality Scores rankings include:
* A novel, highly relevant, objective measure of the quality of work performed by patent law firms.
* Recognition for firms that score well, demonstrating their dedication to patent quality.
* A catalyst for underperforming firms to improve the quality of their work.

Patent Bots will update these rankings on a quarterly basis and highlight firms who are improving their Quality Scores. Moreover, Patent Bots plans on releasing more data-driven insights about other aspects of patent quality to improve the patent industry.

About Patent Bots:

Patent Bots' automated patent proofreading tool enables patent attorneys to use cutting edge machine learning to provide their clients with better patents. In addition to proofreading, Patent Bots has a suite of products that includes patent examiner statistics, an art unit predictor, patent family trees, patent timelines, and more.

Learn more at: https://www.patentbots.com/

*LOGO link for media: https://www.Send2Press.com/300dpi/20-0708s2p-patent-bots-llc-300dpi.jpg

Related link: https://www.patentbots.com/

This news story was published by the Neotrope® News Network - all rights reserved.

Business, Electronics, Free News Articles, Legal and Law, Patent and Trademark

Globest Trading Inc. and Internet Brand Development Resolve Pending Lawsuit with Canon

GLENDORA, Calif. -- Canon Inc., Globest Trading Inc., and Globest's parent company, Internet Brand Development (HK) Limited ("IBD"), have entered into a settlement agreement to amicably resolve the pending lawsuit between Canon and Globest in the Central District of California.

The lawsuit involved the compatible versions of Globest's toner cartridge models CF210X, CF211A, CF212A, CF213A, CB540A, CB541A, CB542A, CB543A, CE320A, CE321A, CE322A, CE323A, CRG-116, CRG-131H, CE410X, CE411A, CE412A, CE413A, CF380X, CF381A, CF382A, CF383A, CC530A, CC531A, CC532A, CC533A, CRG-118, PTCF210A, PTCF211A, PTCF212A, and PTCF213A, which are compatible with Canon toner cartridge models 116, 118, 131, and 131II and HP toner cartridge models 125A, 128A, 131A, 131X, 304A, 305A, 305X, 312A, and 312X, and seven patents that Canon alleged were infringed.

Globest disputed Canon's claim and filed a counterclaim for invalidity, which Canon denied.

To resolve the dispute, Globest agreed to a consent judgment and permanent injunction in which it agreed not to sell the compatible versions of the cartridges listed above that Canon alleged infringed its seven patents, or any similar version that infringes those patents. As part of the settlement, IBD and its affiliates also agreed not to sell those toner cartridges in the U.S. and various other countries.

Nothing in the settlement agreement prevents Globest or IBD from making, using, selling or offering for sale toner cartridges that do not infringe Canon's patents.

The seven patents at issue in the lawsuit are U.S. Patent Nos. 7,869,740 B2, 8,165,494 B2, 8,588,646 B2, 8,971,760 B2, 9,494,916 B2, 9,857,763 B2, and 10,162,304 B2.

Globest Trading is registered in California and sells ink and toner cartridges. IBD is registered in Hong Kong and its primary business is electronic products, office supplies, clothing, instruments and apparatuses and import/export.

This news story was published by the Neotrope® News Network - all rights reserved.